Literature DB >> 29532165

Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial Pneumonias.

Laurens J De Sadeleer1,2, Ellen De Langhe3,4, Nicolas Bodart5, Alain Vigneron5, Xavier Bossuyt6,7, Wim A Wuyts8,9.   

Abstract

Although included in the serological domain of the 'interstitial pneumonia with auto-immune features' (IPAF) research statement, the search for myositis-specific antibodies (MSA) is not incorporated in routine clinical practice. The objective of the study was to evaluate MSA prevalence in an idiopathic interstitial pneumonia (IIP) cohort (n = 68) with suggestive morphological interstitial lung disease patterns. Twelve of 68 patients (17.6%) carried MSA, whereof only two were anti-nuclear antibody-positive. Besides female gender, no demographic or pulmonary function parameter was predictive for MSA positivity. MSA were present in 32.4% of IPAF patients (n = 37), being essential for IPAF diagnosis in four of them (10.8%).

Entities:  

Keywords:  Connective tissue disease-related lung disease; Interstitial lung diseases; Interstitial pneumonia with auto-immune features; Myositis-specific antibodies

Mesh：

Substances：

Year:  2018        PMID： 29532165     DOI： 10.1007/s00408-018-0108-8

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


  15 in total

1.  Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.

Authors:  Sotiris C Plastiras; Fotini C Soliotis; Panayiotis Vlachoyiannopoulos; George E Tzelepis
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

2.  Chest CT findings in patients with inflammatory myopathy and Jo1 antibodies.

Authors:  Stylianos Karadimitrakis; Sotiris C Plastiras; Alexandra Zormpala; Konstantinos Chatzikonstantinou; Kyriaki A Boki; George E Tzelepis; Haralampos M Moutsopoulos
Journal:  Eur J Radiol       Date:  2007-07-02       Impact factor: 3.528

3.  Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.

Authors:  Nobuhide Hayashi; Masahiro Koshiba; Kunihiro Nishimura; Daisuke Sugiyama; Tomoko Nakamura; Sahoko Morinobu; Seiji Kawano; Shunichi Kumagai
Journal:  Mod Rheumatol       Date:  2008-02-19       Impact factor: 3.023

Review 4.  Idiopathic inflammatory myopathies and the lung.

Authors:  Jean-Christophe Lega; Quitterie Reynaud; Alexandre Belot; Nicole Fabien; Isabelle Durieu; Vincent Cottin
Journal:  Eur Respir Rev       Date:  2015-06

5.  Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.

Authors:  Felix Chua; Alexandra M Higton; Alexandra N Colebatch; Katherine O'Reilly; Sisa Grubnic; Ioannis Vlahos; Christopher J Edwards; Patrick D W Kiely
Journal:  Rheumatology (Oxford)       Date:  2012-07-04       Impact factor: 7.580

Review 6.  Occult connective tissue diseases mimicking idiopathic interstitial pneumonias.

Authors:  G E Tzelepis; S P Toya; H M Moutsopoulos
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

7.  Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis.

Authors:  Ho-Cheol Kim; Wonjun Ji; Mi Young Kim; Thomas V Colby; Se Jin Jang; Chang-Keun Lee; Seung Bong Han; Dong Soon Kim
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

8.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  I Marie; E Hachulla; P Chérin; S Dominique; P-Y Hatron; M-F Hellot; B Devulder; S Herson; H Levesque; H Courtois
Journal:  Arthritis Rheum       Date:  2002-12-15

Review 9.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

Review 10.  The X-files in immunity: sex-based differences predispose immune responses.

Authors:  Eleanor N Fish
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106
View more
  6 in total

1.  Screening for Myositis Antibodies in Interstitial Lung Disease.

Authors:  A M O'Mahony; G M Murphy; M T Henry
Journal:  Lung       Date:  2019-04-05       Impact factor: 2.584

2.  Screening for Myositis Antibodies in Idiopathic Interstitial Lung Disease.

Authors:  Lee Fidler; Irena Doubelt; Sonja Kandel; Jolene H Fisher; Shikha Mittoo; Shane Shapera
Journal:  Lung       Date:  2019-03-05       Impact factor: 2.584

3.  Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52/tripartite motif-containing 21 antibodies.

Authors:  Masahiro Tahara; Noriho Sakamoto; Minoru Satoh; Hiroshi Ishimoto; Hirokazu Yura; Kei Yamasaki; Takashi Kido; Yoshihisa Fujino; Tomoko Hasegawa; Shin Tanaka; Kazuhiro Yatera; Hiroshi Mukae
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

4.  Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

Authors:  Minna Jiang; Xin Dong; Yi Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

5.  Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease.

Authors:  Sofia A Moll; Mark G J P Platenburg; Anouk C M Platteel; Adriane D M Vorselaars; Montse Janssen Bonàs; Claudia Roodenburg-Benschop; Bob Meek; Coline H M van Moorsel; Jan C Grutters
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241

6.  Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study.

Authors:  Shamma Ahmad Al Nokhatha; Eman Alfares; Luke Corcoran; Niall Conlon; Richard Conway
Journal:  Rheumatol Int       Date:  2021-10-04       Impact factor: 2.631
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.